Cargando…

Clinicopathological Characteristics and Survival Predictions for Adenocarcinoma of the Esophagogastric Junction: A SEER Population-Based Retrospective Study

OBJECTIVE: Adenocarcinoma of the esophagogastric junction (AEJ) is a relatively rare malignancy in Western countries whose specific clinicopathological characteristics and associated prognosis have not been comprehensively described. METHODS: Data on patients with AEJ between 2005 and 2015 in the Su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xin, Jiang, Qingtao, Yue, Chao, Wang, Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714080/ https://www.ncbi.nlm.nih.gov/pubmed/34992445 http://dx.doi.org/10.2147/IJGM.S341405

Ejemplares similares

Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction
por: Zhou, Zhangjian, et al.
Publicado: (2015)

Development and validation of a novel competing risk model for predicting survival of esophagogastric junction adenocarcinoma: a SEER population-based study and external validation
por: Wang, Tongbo, et al.
Publicado: (2021)

Integrative proteomic characterization of adenocarcinoma of esophagogastric junction
por: Li, Shengli, et al.
Publicado: (2023)

Clinicopathological characteristics and optimal management for esophagogastric junctional cancer; a single center retrospective cohort study
por: Ito, Hiroaki, et al.
Publicado: (2013)

Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study
por: Xu, Haitao, et al.
Publicado: (2020)

Esophagogastric junction adenocarcinoma shares characteristics with gastric adenocarcinoma: Literature review and retrospective multicenter cohort study
por: Imamura, Yu, et al.
Publicado: (2020)

Expression of serum- and glucocorticoid-regulated kinase 1 and its association with clinicopathological factors and the survival of patients with adenocarcinoma of the esophagogastric junction
por: Gao, Shegan, et al.
Publicado: (2017)

Current surgical treatment of esophagogastric junction adenocarcinoma
por: Zhang, Shun, et al.
Publicado: (2019)

Effect of Marital Status on the Survival of Patients With Adenocarcinoma of the Esophagogastric Junction: A Population-Based, Propensity-Matched Study
por: Wang, Sihan, et al.
Publicado: (2021)

Clinicopathological Significance of STAT3 and p-STAT3 among 91 Patients with Adenocarcinoma of the Esophagogastric Junction
por: Ma, Rui-Jie, et al.
Publicado: (2022)

Clinicopathological characteristics and survival outcomes in Paget disease: a SEER population‐based study
por: Zhao, Yang, et al.
Publicado: (2018)

Investigation of BTLA tagging variants with risk of esophagogastric junction adenocarcinoma
por: Tang, Weifeng, et al.
Publicado: (2019)

Current treatments and outlook in adenocarcinoma of the esophagogastric junction: a narrative review
por: Cao, Fei, et al.
Publicado: (2022)

Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction
por: Cai, Ming-Zhi, et al.
Publicado: (2019)

Comparison of Clinicopathological Characteristics in the Patients with Cardiac Cancer with or without Esophagogastric Junctional Invasion: A Single-Center Retrospective Cohort Study
por: Ito, Hiroaki, et al.
Publicado: (2013)

Clinicopathological characteristics and prognosis of colorectal mucinous adenocarcinoma and nonmucinous adenocarcinoma: a surveillance, epidemiology, and end results (SEER) population-based study
por: Li, Zhi-Ping, et al.
Publicado: (2020)

Role of Nampt and Visceral Adiposity in Esophagogastric Junction Adenocarcinoma
por: Li, Haijun, et al.
Publicado: (2017)

Surgical principles for optimal treatment of esophagogastric junction adenocarcinoma
por: Nobel, Tamar, et al.
Publicado: (2019)

Esophagogastric junction adenocarcinoma: Preoperative chemoradiation or perioperative chemotherapy?
por: Laxague, Francisco, et al.
Publicado: (2021)

Clinicopathological characteristics and survival outcomes in breast carcinosarcoma: A SEER population-based study
por: Lin, Shuchen, et al.
Publicado: (2019)

Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2018)

Clinicopathological Characteristics and Survival Outcomes in Invasive Papillary Carcinoma of the Breast: A SEER Population-Based Study
por: Zheng, Yi-Zi, et al.
Publicado: (2016)

Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: A retrospective study of 3 surgical procedures
por: Duan, Xiao-Feng, et al.
Publicado: (2017)

The Association Between Immune Characteristic and Clinical Pathology in Chinese Patients with Adenocarcinoma of Esophagogastric Junction
por: Wang, Yangyang, et al.
Publicado: (2020)

Proximal Gastrectomy versus Total Gastrectomy for Siewert Type II Adenocarcinoma of the Esophagogastric Junction: A Comprehensive Analysis of Data from the SEER Registry
por: Zhu, Kaixuan, et al.
Publicado: (2019)

Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study
por: Liu, Xi-Yu, et al.
Publicado: (2015)

HN1L promotes invasion and metastasis of the esophagogastric junction adenocarcinoma
por: Wang, Zhao Yang, et al.
Publicado: (2021)

Clinical characteristics and prediction model of long time survival of patients with stage M1 Siewert type II esophagogastric junction adenocarcinoma
por: Zhang, Jun, et al.
Publicado: (2021)

Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China
por: Zhang, Hao, et al.
Publicado: (2013)

Clinical Efficacy of Endoscopic Submucosal Dissection for Adenocarcinomas of the Esophagogastric Junction
por: Nagami, Yasuaki, et al.
Publicado: (2014)

Can proximal Gastrectomy Be Justified for Advanced Adenocarcinoma of the Esophagogastric Junction?
por: Sato, Yuya, et al.
Publicado: (2018)

MicroRNAs as Potential Biomarkers for Chemoresistance in Adenocarcinomas of the Esophagogastric Junction
por: Just, Christina, et al.
Publicado: (2019)

Analysis of N(6)-Methyladenosine Methylome in Adenocarcinoma of Esophagogastric Junction
por: Huang, Jia-Bin, et al.
Publicado: (2022)

Recent advances in multidisciplinary therapy for adenocarcinoma of the esophagus and esophagogastric junction
por: Zheng, Yi-Han, et al.
Publicado: (2022)

Esophagogastric junctional neuroendocrine tumor with adenocarcinoma: A case report
por: Kong, Zhen-Zhen, et al.
Publicado: (2022)

The correlation between the margin of resection and prognosis in esophagogastric junction adenocarcinoma
por: Pang, Tao, et al.
Publicado: (2023)

Proposal of a Nomogram for Predicting Survival in Patients with Siewert Type II Adenocarcinoma of the Esophagogastric Junction After Preoperative Radiation
por: Liu, Feng, et al.
Publicado: (2019)

Clinicopathological characteristics and survival outcomes of male breast cancer according to race: A SEER population-based study
por: Sun, He-Fen, et al.
Publicado: (2017)

Clinicopathological characteristics, survival outcomes and prognostic factors in pleomorphic carcinoma: a SEER population-based study
por: Chen, Zhongzhong, et al.
Publicado: (2022)

Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction
por: Wang, Wen-Ping, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vq574tieo2vquc9caa0de6bsic